Almac Diagnostics Sees Benefit for Test Pipeline in New Ovarian, Breast Cancer Studies

Almac researchers and academic collaborators used the company's Disease Specific Array platform to identify biomarkers associated with ovarian and breast cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.